Blood–Brain Barrier Targeting of Therapeutic Lysosomal Enzymes
Author:
Pardridge William M.
Publisher
Springer New York
Reference50 articles.
1. Al Sawaf S, Mayatepek E, Hoffmann B (2008) Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed. J Inherit Metab Dis 31:473–480
2. Blasberg RG, Patlak C, Fenstermacher JD (1975) Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. J Pharmacol Exp Ther 195:73–83
3. Boado RJ, Pardridge WM (2009) Comparison of blood–brain barrier transport of GDNF and an IgG-GDNF fusion protein in the Rhesus monkey. Drug Metab Dispos 37:2299–2304
4. Boado RJ, Zhang Y, Pardridge WM (2007) Humanization of anti-human insulin receptor antibody for drug targeting across the human blood–brain barrier. Biotechnol Bioeng 96:381–391
5. Boado RJ, Zhang Y, Xia CF, Wang Y, Pardridge WM (2008) Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood–brain barrier. Biotechnol Bioeng 99:475–484